N
NovaBay Pharmaceuticals, Inc. (NBY)
ASE – Real vaqt narxi. Valyuta: USD
1.95
+0.36 (22.64%)
Yopilishda: Apr 2, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
ASE – Real vaqt narxi. Valyuta: USD
1.95
+0.36 (22.64%)
Yopilishda: Apr 2, 2026, 4:00 PM EDT
Daromad taqsimoti ma'lumotlari hali hisoblanmagan.
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Kompaniyaning naqd pul zahiralari $18.4M umumiy qarzdan $637.0K sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $18.9M jami joriy majburiyatlardan $3.6M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.0) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (-128.3x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$1.8M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 5.29 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 5.29 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 0.00 | 0.30 | 10 | |
| Qarz/Aktivlar nisbati | 0.00 | 1.04 | 10 | |
| Foiz to‘lov qoplami | -128.33 | -16.91 | 1.0 | |
| O‘rtacha ball | 8.2 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 14M | 10M | N/A | N/A | 3M |
| Yalpi foyda | 8M | 6M | -341K | -140K | -51K |
| Operatsion daromad | -8M | -4M | -7M | -8M | -6M |
| Sof foyda | -16M | -6M | -7M | -642M | 546M |
| EBITDA | -7M | -4M | -7M | -7M | -6M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | N/A | N/A | 1.0 |
| Keyingi chorak | N/A | 47.83 | 5.5 |
| Joriy yil | N/A | N/A | 1.0 |
| Keyingi yil | N/A | N/A | 1.0 |
| O‘rtacha ball | 2.1 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 372.74 | 42822.58 | N/A | 1.96 | 6.0 |
| Yil/Yil | 999 | 45677.81 | 61.67 | -15.71 | 7.8 |
| 3 yil o‘rtacha | 290.53 | -2914.42 | 79.48 | -16.94 | 5.5 |
| 5 yil o‘rtacha | 183.1 | -1775.06 | 29.55 | -23.15 | 5.5 |
| O‘rtacha ball | 6.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | 0.00 | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | 0.00 | 0.00 | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |